BiomÃ©rieux

Company Snapshot

Founded: 1963

Entity Type: Public

Employees: 13800

Region: Americas

Revenue: $3,779.5 Millions

Revenue Year: 2022

Headquarter: Marcy l'Etoile, France

Key Geographics: Americas, Europe, Middle East and Africa, Asia-Pacific

Company Overview

BioMérieux is listed on the NYSE Euronext. The company focuses on diagnostic solutions (reagents, instruments, software and services) that determine the source of disease and contamination to improve patient health and ensure product safety.

BiomÃ©rieux In Reports

Molecular Diagnostics: Technologies and Global Markets

According to our research analyst the molecular diagnostics market includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.

Global Biochip Markets: Microarrays and Lab-on-a-Chip

BCC Research Market Analyst says global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a CAGR of 11.6%.

Oncology Diagnostics: Global Markets

BCC Research Report: Dive into oncology diagnostics market revenues can be estimated based on the product category, by application, by end user and by region.

View All Reports

Total Lab Automation Market Report 2023-2030 : Recent Trends - openPR.com

openPR.com - Feb 17, 2023

Company's Business Segments

Clinical Applications : Immunoassays, Molecular biology, Microbiology, and Other ranges.
Industrial Applications : Food and Pharma Quality Control

Applications/End User Industries

Hospitals
Laboratory
Point Of Care
Food Safety & Quality

Pharma Quality Control
Product Quality & Safety
Customer Service
Cybersecurity